# Daniel K. Nomura

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-k-nomura/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,710 |
| Field | Protein Degradation and Inhibitors |
| h-index | 81 |
| i10-index | 173 |
| Last Known Institution | Novartis (Switzerland) |
| OpenAlex ID | https://openalex.org/A5035184259 |
| ORCID iD | https://orcid.org/0000-0003-1614-8360 |
| Works | 288 |

## Researcher papers

- [Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer](https://scholariq.org/papers/suppressing-fatty-acid-uptake-has-therapeutic-effects-in-preclinical-models-of/)

## Researcher topics

- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways-2/)
- [Click Chemistry and Applications](https://scholariq.org/topics/click-chemistry-and-applications/)
- [Cannabis and Cannabinoid Research](https://scholariq.org/topics/cannabis-and-cannabinoid-research/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

## Researcher university

- [Novartis (Switzerland)](https://scholariq.org/institutions/novartis-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.